For a psychiatrist or therapist, the 15 minutes after a patient leaves the room are often the most draining. That is the window for clinical documentation, a mandatory administrative task that pulls focus from the person just treated and contributes to the industry’s staggering burnout rates. Nextvisit AI, a pre-seed startup founded in 2021, is betting that passive, AI-driven note capture during the session itself can give that time back. The company’s early traction, reported at $9,000 in monthly recurring revenue from 68 paying customers, suggests a small but growing group of behavioral health providers are willing to test that promise [LinkedIn, 2025].
A wedge built on clinical nuance
Nextvisit’s product is an AI scribe that transcribes patient conversations in real time and automatically generates structured clinical notes, such as SOAP notes and intake documentation [Nextvisit.ai, 2025]. The core claim is that it is built exclusively for behavioral health, a distinction its founders argue is critical. A generic medical scribe might miss the longitudinal patterns of a psychiatric history or the nuanced language of a therapeutic dialogue. Co-founder Ryan Yannelli, a health technology engineer, has publicly outlined factors providers should evaluate, emphasizing the need for tools that understand the specific workflows and terminology of mental health care [Asbury Park Press, 2026]. The other co-founder, Dr. Faisal Rafiq, brings 15 years of practicing psychiatry to the product’s design, aiming to ensure it aligns with real clinical judgment rather than just transcription accuracy [Doximity, 2026].
The early-stage foundation
The company’s foundation is characteristic of a very early venture. It graduated from Jason Calacanis’s LAUNCH Accelerator, which typically provides a small pre-seed investment and mentorship, and has since joined Intercom’s startup program [Nextvisit Press Room, May 2025]. A $200,000 pre-seed round led by the LAUNCH Fund provides the initial capital [PitchBook, 2025]. The team remains small, estimated between two and ten employees. The current leadership and funding landscape is summarized below.
| Role / Aspect | Detail | Source |
|---|---|---|
| Co-Founder & Clinician | Dr. Faisal Rafiq, practicing psychiatrist with 15 years of experience | [Doximity, 2026] |
| Co-Founder & CTO | Ryan Yannelli, software engineer with 15 years in health technology | [Ryan Yannelli, 2026] |
| Funding Stage | Pre-seed | [PitchBook, 2025] |
| Disclosed Funding | $200,000 | [PitchBook, 2025] |
| Key Investor | LAUNCH Fund | [PitchBook, 2025] |
The path from early adoption to clinical trust
The leap from a few dozen early adopters to widespread clinical use is formidable. Nextvisit’s public claims of being "trusted by 1,000+ health organizations" appear to refer to a broader user base, perhaps including free tiers or pilots, while the paying customer count sits at 68 [Nextvisit.ai, LinkedIn 2025]. The risks facing the company are not unique, but they are acute in the heavily regulated healthcare sector.
- Clinical accuracy and liability. An AI-generated note that misses a critical detail or misinterprets a patient statement is not just an error; it is a potential clinical and legal liability. The company will need to demonstrate, likely through peer-reviewed studies, that its output is not only accurate but reliably safe.
- Regulatory navigation. While AI scribes may currently fall under FDA enforcement discretion for certain clinical decision support software, the regulatory environment is evolving. Proactively engaging with FDA guidelines for Software as a Medical Device (SaMD) could become necessary.
- Integration and workflow. The tool’s value diminishes if it creates extra steps or fails to integrate seamlessly with the major electronic health record systems used by behavioral health practices. Deep, bi-directional integrations are a significant development lift.
- Market competition. While no direct competitors are named in the sources, the space for AI clinical documentation is crowded. Larger, well-funded companies building general-purpose medical scribes could easily develop behavioral health modules, leveraging their scale and existing sales channels.
Success for Nextvisit will depend on moving beyond a useful transcription tool to becoming an indispensable clinical partner. That means proving its AI understands context, preserves clinician intent, and improves outcomes,or at the very least, does no harm. The next twelve months will likely focus on converting pilot programs into larger organizational contracts and beginning the long process of gathering clinical validation data.
The patient population here is anyone seeking mental health care from an overwhelmed provider. The disease state is a systemic one: clinician burnout, driven by administrative burden, which contributes to provider shortages and reduced quality of care. Today, the standard of care for documentation is a manual, time-consuming process. A therapist might spend part of a session typing notes, or more commonly, dedicate the time between appointments to charting, often extending their workday. Dictation services exist but require the clinician to verbally structure the note afterward. Nextvisit’s bet is that silent, ambient AI can remove this task almost entirely, letting the clinician’s attention remain wholly on the patient in the room. It is a humane goal, measured in minutes given back and in the quality of a therapist’s focus.
Sources
- [Asbury Park Press, 2026] Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026 | https://www.app.com/press-release/story/17446/nextvisit-co-founder-ryan-yannelli-identifies-six-critical-factors-for-behavioral-health-providers-evaluating-ai-scribes-in-2026/
- [Doximity, 2026] Dr. Faisal Rafiq, MD - Amityville, NY | Psychiatry on Doximity | https://www.doximity.com/pub/faisal-rafiq-md
- [LinkedIn, 2025] Nextvisit Inc | LinkedIn | https://www.linkedin.com/company/nextvisit-inc
- [Nextvisit.ai, 2025] Nextvisit AI Medical Scribe | https://nextvisit.ai/
- [Nextvisit Press Room, May 2025] Nextvisit AI Joins Intercom Startup Program | https://news.nextvisit.ai/91082-nextvisit-ai-joins-intercom-startup-program-accelerates-support-capabilities-to-meet-growing-demand-in-behavioral-health-tech
- [PitchBook, 2025] Nextvisit AI 2025 Company Profile: Valuation, Funding & Investors | PitchBook | https://pitchbook.com/profiles/company/567518-50
- [Ryan Yannelli, 2026] Ryan Yannelli | Technologist, Founder, Advocate | https://ryanyannelli.com/